HYDROXYBUTYRATE DEHYDROGENASE (HBDH) - class ii - ANVISA Registration 80158990137

Access comprehensive regulatory information for HYDROXYBUTYRATE DEHYDROGENASE (HBDH) - class ii in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80158990137 and manufactured by RANDOX LABORATORIES LTD. The registration is held by RANDOX BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 3 companies making the same product including SENTINEL CH SPA, SENTINEL CH. SPA, and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.